2018 American Transplant Congress
Malignancy Complications after Kidney Transplantation, the Role of Immunosuppression
Introduction: Immunosuppression therapy is essential to avoid rejection after kidney transplantation. The chronic use of this drugs increases the risk of malignancy compared to general…2018 American Transplant Congress
Patient Change in Residence and Risk of Readmission after Renal Transplant in the US
Emory University, Atlanta, GA.
To predict readmission post-kidney transplant (KTX-R), novel risk factors must be identified. We investigated the impact of a) neighborhood (zipcode) and its attributes and b)…2018 American Transplant Congress
Renal Allograft Molecular Pathways Associated with Tolerance Induction in Renal Transplantation
Background: Chronic exposure to immunosuppressive agents for organ transplant results in graft nephrotoxicity, infections and malignancies We have established durable immune tolerance in mismatched related…2018 American Transplant Congress
Kidney after Liver Transplant: A Matched Pair Analysis
Surgery, University of Wisconsin, Madison, WI.
Background: Kidney after liver (KAL) transplantation is the best therapeutic option for patients with ESRD after liver transplantation (OLT). Current allocation policies create a safety…2018 American Transplant Congress
Kidney Transplantation in Older Recipients: Preemptive High KDPI Kidney vs. Lower KDPI Kidney after Varying Dialysis Vintage
Nephrology and Hypertension, Allegheny General Hospital, Pittsburgh, PA.
Dialysis vintage is an independent predictor of adverse long-term kidney transplant outcomes. Transplantation of "marginal" kidneys also results in inferior outcomes. We sought to analyze…2018 American Transplant Congress
Differences in Rejection and Clinical Outcomes in Obese versus Non-Obese Renal Transplant Recipients Receiving Basiliximab Induction Immunosuppression
Introduction: Basilixiab is a fixed-dose IL-2 receptor antagonist that is used for non-lymphodepleting induction therapy. The impact of obesity on basiliximab pharmacokinetics and pharmacodynamics is…2018 American Transplant Congress
Age Stratified Efficacy and Safety Outcomes of Induction Immunosuppression in Renal Transplantation
Purpose: Rejection and infection remain a leading concern for decreased graft survival after renal transplant (RT). Induction immunosuppression is associated with a decreased risk of…2018 American Transplant Congress
Kidney Transplant Outcome in the Patients with Lupus Nephritis
Background: Despite improvements in overall prognosis in lupus nephritis, 10%-30% of patients with proliferative renal involvement progress to end stage renal disease, and kidney transplantation…2018 American Transplant Congress
Validation of Edmonton Symptom Assessment Survey in Kidney Transplant Recipients (KTR)
Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada.
Background: Patient-reported outcomes provide important information about symptom and illness experience of patients with chronic medical conditions. The Edmonton Symptom Assessment System (ESAS) is a…2018 American Transplant Congress
Long Term IVIG Infusions for Treatment of Chronic Antibody Mediated Rejection in Pediatric Kidney Transplant Recipients
Objectives: The emergence of donor specific antibodies (DSA) after kidney transplantation (Tx) is associated with lower graft survival. The benefit of using intravenous gamma globulin…
- « Previous Page
- 1
- …
- 292
- 293
- 294
- 295
- 296
- …
- 531
- Next Page »